Avalo Therapeutics, Inc.
AVTX$13.61▼ 0.95% 24h
Avalo Therapeutics, Inc.AVTX$13.61
+$7.79(+133.83%)Past Year
Jun 25Sep 25Dec 25Mar 26Jun 26
Key statistics
Market cap
$310.15M
P/E ratio
—
EPS (diluted)
$-5.84
Dividend yield
0.00%
Dividend / share
$0.00
Revenue
$59,000
Net income
$-78.26M
Net margin
-132642.4%
Gross margin
—
Dividends & financials
Avalo Therapeutics, Inc. (AVTX) reported revenue of $59,000 and net income of $-78.26M, or $-5.84 per diluted share. It does not currently pay a dividend. Financial figures are sourced from the company’s latest public filings; the price chart updates live, 24/7, even when the underlying market is closed.